In AD, PGSs may explain additional disease risk beyond the apolipoprotein E (APOE) locus and have been associated with age of onset, disease progression, and clinical measures such as cognitive decline and biofluid and neuroimaging biomarkers.4, 5, 6, 7, 8, 9, 10. Here, APOE is linked to Mental deterioration.